Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RUNX3 protein is overexpressed in human basal cell carcinomas.

M Salto-Tellez1, B K Peh, K Ito

  • 1Department of Pathology, National University Hospital, Yong Loo Lin Medical School, National University of Singapore (NUS), Singapore, Singapore.

Oncogene
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial Wall Stiffening in Caveolin-1 Deficiency-Induced Pulmonary Artery Hypertension in Mice.

Experimental mechanics·2021
Same author

Disc degeneration induces a mechano-sensitization of disc afferent nerve fibers that associates with low back pain.

Osteoarthritis and cartilage·2019
Same author

Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.

Oncogene·2017
Same author

Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synovium.

Osteoarthritis and cartilage·2012
Same author

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.

British journal of cancer·2009
Same author

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

RUNX3 is overexpressed in basal cell carcinoma (BCC) and may act as an oncogene. This study suggests RUNX3 is a key mediator in this common skin cancer, potentially driven by the Sonic Hedgehog (Shh) pathway.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Basal cell carcinoma (BCC) is the most common skin cancer.
  • BCC pathogenesis is linked to Sonic Hedgehog (Shh) pathway deregulation.
  • Understanding Shh pathway interactions is crucial for BCC research.

Purpose of the Study:

  • To investigate the expression and role of beta-catenin and RUNX3 in BCC.
  • To determine if RUNX3 acts as an oncogene in BCC.
  • To elucidate the relationship between Shh, Wnt, and bone morphogenetic protein/transforming growth factor-beta pathways in BCC.

Main Methods:

  • Tissue microarray (TMA) construction of 75 paired BCC and normal skin samples.
  • Analysis of beta-catenin and RUNX3 expression using TMA.

Related Experiment Videos

  • Western blotting and DNA sequencing to assess RUNX3 protein integrity and mutations.

    • Main Results:

    • Beta-catenin showed varying subcellular expression, with nuclear accumulation in 41% of BCC cases.
    • RUNX3 protein was uniformly overexpressed in the nuclei of all tested BCC cells.
    • Western blotting and DNA sequencing confirmed RUNX3 is normal, full-length, and non-mutated in the coding region.

    Conclusions:

    • While Wnt pathway deregulation may contribute to some BCC cases, RUNX3 appears to be a universal downstream mediator.
    • RUNX3's consistent overexpression suggests its role as an oncogene in BCC.
    • RUNX3 may be a critical component of the constitutively active Shh pathway in basal cell carcinoma.